FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1797564483> ?p ?o ?g. }

• W1797564483 endingPage "1135" @default.
• W1797564483 startingPage "1128" @default.
• W1797564483 abstract "Non-vitamin K oral anticoagulants (NOACs) became available in the Netherlands in 2008, providing another antithrombotic treatment besides vitamin K antagonists (VKAs) and antiplatelet agents (APAs).To describe the patterns of antithrombotic drug use between 2008 and 2013 by examination of dispensing data form community pharmacies in the Netherlands; to determine the concomitant use of NOACs with VKAs and APAs and switching between the drug classes; and to compare adherence to NOACs with adherence to APAs.An observational retrospective study was conducted using routinely collected dispensing data from Dutch community pharmacies.For each calendar year, the numbers of NOAC, VKA, and APA users were calculated. Adherence was determined for NOACs and APAs by the percentage of days covered by medication (PDC). Information on the prescribed daily dose of VKAs was unavailable.Comparison of age, sex, and co-medications of users of the three drug classes; concomitant use of different antithrombotic drug classes and switching between these in each year; and mean PDC and percentages of all users with a PDC above 80 %.NOAC use increased during the study period to 29,687 users in 2013. In that year there were 484,024 VKA users and 1313,032 APA users. Compared with users of VKAs, NOAC users were slightly younger and more frequently used antiarrhythmic drugs and beta blockers as co-medications. Substantial numbers of patients were dispensed potentially harmful combinations in 2013: 820 subjects were dispensed NOACs together with VKAs, and 684 subjects were dispensed NOACs, VKAs, and APAs concomitantly. Mean adherence to NOACs was 84.2 % compared with 87.3 % to APA. One in four NOAC users had a PDC lower than 80 % compared with one in five APA users.Our findings show increasing use of NOACs by outpatients. The number of patients taking potentially harmful combinations of antithrombotic drugs was substantial. Adherence to NOACs in daily practice may be suboptimal to prevent thrombotic events." @default.
• W1797564483 created "2016-06-24" @default.
• W1797564483 creator A5006953234 @default.
• W1797564483 creator A5013410594 @default.
• W1797564483 creator A5023121314 @default.
• W1797564483 creator A5038172512 @default.
• W1797564483 creator A5069168470 @default.
• W1797564483 creator A5071945710 @default.
• W1797564483 creator A5081818861 @default.
• W1797564483 date "2015-08-05" @default.
• W1797564483 modified "2023-09-27" @default.
• W1797564483 title "Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands" @default.
• W1797564483 cites W1534687747 @default.
• W1797564483 cites W159560641 @default.
• W1797564483 cites W1977575772 @default.
• W1797564483 cites W1984341697 @default.
• W1797564483 cites W2011936209 @default.
• W1797564483 cites W2012838423 @default.
• W1797564483 cites W2014783633 @default.
• W1797564483 cites W2014883445 @default.
• W1797564483 cites W2015854890 @default.
• W1797564483 cites W2037445407 @default.
• W1797564483 cites W2043793746 @default.
• W1797564483 cites W2062705106 @default.
• W1797564483 cites W2062765161 @default.
• W1797564483 cites W2074206824 @default.
• W1797564483 cites W2083520956 @default.
• W1797564483 cites W2096329415 @default.
• W1797564483 cites W2097854437 @default.
• W1797564483 cites W2098214860 @default.
• W1797564483 cites W2101863341 @default.
• W1797564483 cites W2110145942 @default.
• W1797564483 cites W2112109826 @default.
• W1797564483 cites W2118092611 @default.
• W1797564483 cites W2119562205 @default.
• W1797564483 cites W2136489990 @default.
• W1797564483 cites W2137669083 @default.
• W1797564483 cites W2139062201 @default.
• W1797564483 cites W2143034156 @default.
• W1797564483 cites W2144939065 @default.
• W1797564483 cites W2162508946 @default.
• W1797564483 cites W2164643105 @default.
• W1797564483 cites W2164861810 @default.
• W1797564483 cites W2171420208 @default.
• W1797564483 cites W2322592734 @default.
• W1797564483 doi "https://doi.org/10.1007/s11096-015-0174-4" @default.
• W1797564483 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4619456" @default.
• W1797564483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26243531" @default.
• W1797564483 hasPublicationYear "2015" @default.
• W1797564483 type Work @default.
• W1797564483 sameAs 1797564483 @default.
• W1797564483 citedByCount "41" @default.
• W1797564483 countsByYear W17975644832016 @default.
• W1797564483 countsByYear W17975644832017 @default.
• W1797564483 countsByYear W17975644832018 @default.
• W1797564483 countsByYear W17975644832019 @default.
• W1797564483 countsByYear W17975644832020 @default.
• W1797564483 countsByYear W17975644832021 @default.
• W1797564483 countsByYear W17975644832022 @default.
• W1797564483 countsByYear W17975644832023 @default.
• W1797564483 crossrefType "journal-article" @default.
• W1797564483 hasAuthorship W1797564483A5006953234 @default.
• W1797564483 hasAuthorship W1797564483A5013410594 @default.
• W1797564483 hasAuthorship W1797564483A5023121314 @default.
• W1797564483 hasAuthorship W1797564483A5038172512 @default.
• W1797564483 hasAuthorship W1797564483A5069168470 @default.
• W1797564483 hasAuthorship W1797564483A5071945710 @default.
• W1797564483 hasAuthorship W1797564483A5081818861 @default.
• W1797564483 hasBestOaLocation W17975644831 @default.
• W1797564483 hasConcept C104863432 @default.
• W1797564483 hasConcept C126322002 @default.
• W1797564483 hasConcept C23131810 @default.
• W1797564483 hasConcept C2777015399 @default.
• W1797564483 hasConcept C2779384505 @default.
• W1797564483 hasConcept C2780035454 @default.
• W1797564483 hasConcept C2993590494 @default.
• W1797564483 hasConcept C512399662 @default.
• W1797564483 hasConcept C71924100 @default.
• W1797564483 hasConcept C98274493 @default.
• W1797564483 hasConceptScore W1797564483C104863432 @default.
• W1797564483 hasConceptScore W1797564483C126322002 @default.
• W1797564483 hasConceptScore W1797564483C23131810 @default.
• W1797564483 hasConceptScore W1797564483C2777015399 @default.
• W1797564483 hasConceptScore W1797564483C2779384505 @default.
• W1797564483 hasConceptScore W1797564483C2780035454 @default.
• W1797564483 hasConceptScore W1797564483C2993590494 @default.
• W1797564483 hasConceptScore W1797564483C512399662 @default.
• W1797564483 hasConceptScore W1797564483C71924100 @default.
• W1797564483 hasConceptScore W1797564483C98274493 @default.
• W1797564483 hasIssue "6" @default.
• W1797564483 hasLocation W17975644831 @default.
• W1797564483 hasLocation W17975644832 @default.
• W1797564483 hasLocation W17975644833 @default.
• W1797564483 hasLocation W17975644834 @default.
• W1797564483 hasLocation W17975644835 @default.
• W1797564483 hasLocation W17975644836 @default.
• W1797564483 hasOpenAccess W1797564483 @default.
• W1797564483 hasPrimaryLocation W17975644831 @default.

• next